.jpg)
Alzheimer's Disease
This clinical trial is now CLOSED
​
Current therapies for Alzheimer's may provide symptomatic relief from cognitive difficulties however, they only produce a modest effect and are accompanied by dose-limiting side effects, such as nausea, vomiting, diarrhoea, muscle cramps and general malaise.
​
This study will investigate if the early intervention with a new medication can help to prevent the condition from deteriorating.
​
​
Are you currently aged between 50-90?
Have Been diagnosed with mild to moderate Alzheimer's disease​?
If you have answered YES to the questions above, you may be eligible to be part of a new trial being held in Christchurch.​ This trial will investigate if the early administration of the investigative product can help to prevent the condition from deteriorating.
​
If you're interested in learning more about the study, please fill out the form below or call us on 03 365 6777
